Home/Agendia/Stephanie Bywater
SB

Stephanie Bywater

Chief Compliance Officer

Agendia

Therapeutic Areas

Agendia Pipeline

DrugIndicationPhase
MammaPrint/BluePrint Clinical Utility ExpansionEarly-Stage Breast CancerCommercial
Real-World Evidence (FLEX Study)Early-Stage Breast CancerObservational Study
Guideline Integration & Payer EngagementBreast Cancer DiagnosticsCommercial